TickerFacts.

AEON Biopharma, Inc. (AEON): Capital Expenditures

Annual figures by period end, from SEC filings.

$4.0K
Year ended 2025-12-31
-76.4%
3-year compound annual growth
$306.0K2022-12-31: $306.0K2025-12-31: $4.0K$4.0K
2022-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$4.0Kn/a2026-03-30, From 2025-01-01
No annual figure between 2022-12-31 and 2025-12-31.
2022-12-31$306.0Kn/a2024-05-14, From 2022-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
AEON Biopharma, Inc. (AEON)2025-12-31$4.0Kn/a
CDT Equity Inc. (CDT)2024-12-31$51.0Kn/a
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$139.9K+34.8%
Quantum Cyber N.V. (QUCY)2025-12-31$1.2K-98.8%
Ernexa Therapeutics Inc. (ERNA)2025-12-31$37.0K-90.0%
Petros Pharmaceuticals, Inc. (PTPI)2024-12-31$24.6Kn/a
Azitra, Inc. (AZTR)2025-12-31$24.2K+182.6%
GeoVax Labs, Inc. (GOVX)2025-12-31$27.6K+33.7%
International Stem Cell Corp (ISCO)2025-12-31$43.0K-74.1%

Compare AEON, CDT, SXTP, QUCY side by side · Screen every company in Pharmaceutical Preparations ↗